Although some database analyses have suggested that the use of 5ARIs can lead to delayed diagnosis and worse cancer-specific mortality [13], it is likely that these negative outcomes resulted from use of unadjusted PSA levels, potentially leading to incorrect PSA interpretation. This evidence concerns the gene KLK3 and cancer.